US Patent Issued to University of Southern California on March 17 for "Compositions and methods for modulating inflammatory and degenerative disorder" (California Inventor)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,238, issued on March 17, was assigned to University of Southern California (Los Angeles).

"Compositions and methods for modulating inflammatory and degenerative disorder" was invented by Denis Evseenko (Tarzana, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides compounds and method useful for modulating gp130 biological activity. The disclosure also provides methods and compositions for treating disease and disorders associated with gp130 activity, particularly those associated with inflammation."

The patent was filed on Aug. 17, 2022, under Application No. 17/820,522.

*For further information, including images, charts...